EnsoData adds position data to sleep test 

MADISON, Wis. – The FDA-cleared EnsoSleep PPG home sleep test now features position data captured by Advanced Brain Monitoring’s Night Shift sleep positioner. Incorporating positional data provides a more complete diagnostic picture of the patient’s sleep: 21% of sleep apnea patients would have little-to-no breathing problems if back-sleeping were avoided, and 70% of patients diagnosed with OSA are substantially more severe when back-sleeping, according to ABM research. “The integration is designed to help recognize more patients who may have a positional component contributing to the severity of their sleep-disordered breathing,” said Daniel J. Levendowski, president, Advanced Brain Monitoring. “This improvement in the HSAT could result in a more personalized approach for first-line OSA therapy recommendations and/or improved selection of alternative therapies for patients who fail to adapt to CPAP.” The FDA-cleared Night Shift records positional data that will be displayed in EnsoSleep PPG Study Management and can be added to dynamic patient reports. Incorporating more data through multi-night, multi-sensor testing will provide a more comprehensive understanding of overall sleep issues across the patient population, allowing providers to better diagnose conditions like positional sleep apnea, according to EnsoData. “When one in five patients suffering from OSA can be treated with simple body position adjustment therapy, it’s time to address that patient population head on,” said Brock Hensen, COO, EnsoData. “By adding sleep position data provided by Advanced Brain Monitoring’s Night Shift, we can instill physician confidence in new home sleep testing modalities that provide accurate diagnostic data in simple, affordable form factors to replace aging legacy devices.”